Table of Contents
PPT Slide
Safe Harbour Statement
SkyePharma - Company Overview
SkyePharma’s Mission
Increased Need for Drug Delivery
Main Sectors of Drug Delivery
SkyePharma’s Strategy
SkyePharma’s Technologies
Major Clients
2000 Key Value Drivers
DepoCyt™ - Near-term revenue driver
Xatral® 10mg OD
Solarase™
DepoMorphine™
Paxil™ CR
Requip™
Foradil - Novartis
Chiral Beta Agonist - Sepracor
PPT Slide
PPT Slide
New Product Partnerships
Business Development 97-99
PPT Slide
PPT Slide
DepoFoam™ - Injectable Delivery Technology
DepoFoam Versatility
SkyePharma’s Dry Powder Inhaler
SkyePharma DPI - 12 Month Storage
SkyePharma Non CFC MDI
SkyeFine™ Formulation Technology
GEOMATRIX® - Competitive Advantage
Geomatrix® - Formulation Flexibility
Enhancement Solubility Technology
Saturation solubility of model drug A
Topical - HA
Financial Overview
PPT Slide
|